Revive Therapeutics Ltd (RVVTF)

[medicinecat]

I couldn't agree more dude. There is demand in India with no supply. 1+1=2. Why hasn't Pfizer and all their educated, brainiacs gone to India??? I don't get it. Anyway...Merck just signed a deal, strangely announced on the day after the Revive India news, for 1.2 billion dollars with the U.S. government to supply the oral Covid drug molnupiravir. They are also in Phase 3 and seeking an EUA from the FDA just like we are. So why not us? Now if all of us got together in one room this would be a very long discussion, but to me it's all about supply and demand. Pfizer and Roche are right behind Merck with an oral med that the U.S. is already eye-balling. Does MF see the U.S. demand drying up because it's too crowded? If that's the case then he's adapting which is a good thing. He's doing what a good CEO would do and go somewhere else. I agree with everyone on that. However Merck is at nearly the same clinical stage and development as we are, but the difference, they have 1.2 billion dollars in their pocket. Let me say that again...they have 1.2 billion dollars in their pocket. Why not us?